Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to treatment for people with alopecia areata in Gloucester.

The Government is committed to supporting all those living with dermatological conditions, including alopecia areata. Dermatology services are being transformed to make sure that patients are seen on time. NHS England’s Getting It Right First Time Programme for Dermatology is working with National Health Service trusts to deliver rapid clinical transformation. The work brings together clinicians and operational teams to work collectively to transform patient pathways, reduce unnecessary appointments, and improve access and waiting times for patients.

In March 2024, the National Institute for Health and Care Excellence (NICE) recommended ritlecitinib as an option for treating severe alopecia areata in people 12 years old and over. The NHS is legally required to make funding available for treatments recommended in NICE technology appraisal guidance within three months of publication of the guidance, opening the way for patients across the country, including in Gloucester, to access this treatment.

It is a clinician’s responsibility to make decisions appropriate to the circumstances of their patient, whilst ensuring they are taking account of appropriate national guidance on clinical effectiveness, as well as the local commissioning decisions of their respective integrated care board (ICB), in this case the NHS Gloucestershire ICB.